CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $372,809,000 | $357,776,000 | $322,467,000 | $292,111,000 |
| % Growth | 4.2% | 10.9% | 10.4% | – |
| Cost of Goods Sold | $321,408,000 | $303,345,000 | $267,965,000 | $239,991,000 |
| Gross Profit | $51,401,000 | $54,431,000 | $54,502,000 | $52,120,000 |
| % Margin | 13.8% | 15.2% | 16.9% | 17.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $40,240,000 | $0 | $0 | $0 |
| SG&A Expenses | $41,229,000 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $989,000 | $0 | $0 | $0 |
| Other Operating Expenses | $1,656,000 | $40,688,000 | $46,548,000 | $38,810,000 |
| Operating Expenses | $42,885,000 | $40,688,000 | $46,548,000 | $38,810,000 |
| Operating Income | $8,516,000 | $13,743,000 | $7,954,000 | $13,310,000 |
| % Margin | 2.3% | 3.8% | 2.5% | 4.6% |
| Other Income/Exp. Net | -$2,368,000 | -$2,570,000 | -$2,118,000 | -$2,773,000 |
| Pre-Tax Income | $6,148,000 | $11,173,000 | $5,836,000 | $10,537,000 |
| Tax Expense | $1,562,000 | $2,805,000 | $1,509,000 | $2,548,000 |
| Net Income | $4,614,000 | $8,344,000 | $4,311,000 | $8,001,000 |
| % Margin | 1.2% | 2.3% | 1.3% | 2.7% |
| EPS | 3.66 | 6.49 | 3.29 | 6 |
| % Growth | -43.6% | 97.3% | -45.2% | – |
| EPS Diluted | 3.66 | 6.47 | 3.26 | 5.95 |
| Weighted Avg Shares Out | 1,259,000 | 1,285,000 | 1,312,000 | 1,319,000 |
| Weighted Avg Shares Out Dil | 1,262,000 | 1,290,000 | 1,323,000 | 1,329,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,958,000 | $2,658,000 | $2,287,000 | $2,503,000 |
| Depreciation & Amortization | $4,597,000 | $4,366,000 | $4,224,000 | $4,486,000 |
| EBITDA | $13,683,000 | $18,197,000 | $12,347,000 | $17,526,000 |
| % Margin | 3.7% | 5.1% | 3.8% | 6% |